Pyrin变异E148Q增强炎症小体活化及顺式致病突变效应
研究通过澳大利亚自身炎症性疾病登记库(AADRY)分析pyrin p.E148Q变异的遗传模式,并在HEK293T和THP-1细胞中验证其功能。发现p.E148Q可自发增强炎症小体形成及IL-1β、IL-18分泌,与经典FMF突变顺式组合时效应叠加,部分家系中可解释FMF呈显性遗传。
要点
- pyrin p.E148Q在体外可自发增强炎症小体形成并增加IL-1β和IL-18分泌。
- p.E148Q与经典FMF突变顺式组合时对炎症小体形成提供显著叠加增强。
- 两个FMF家系携带p.E148Q-M694I顺式等位基因并呈显性遗传。
核心结论
- pyrin p.E148Q变异在体外增强炎症小体活化,与已知致病FMF突变顺式组合时效应叠加,部分家系中可解释FMF呈显性遗传。
研究设计与样本
- 利用澳大利亚自身炎症性疾病登记库(AADRY)寻找pyrin p.E148Q变异的候选遗传模式。
- 在稳定表达接头蛋白ASC的HEK293T细胞中测试不同pyrin变异组合,用流式细胞术观察炎症小体形成,并设有无艰难梭菌毒素B(TcdB)刺激条件。
- 用慢病毒表达载体转导THP-1细胞,通过ELISA定量上清中炎症小体依赖性细胞因子分泌。
主要发现
- 在AADRY中观察到p.E148Q等位基因存在于单独或合并其他pyrin变异的自身炎症性疾病个体中。
- 两个FMF家系携带p.E148Q-M694I顺式等位基因并呈显性遗传。
- 体外实验中,p.E148Q pyrin可自发增强炎症小体形成,并增加IL-1β和IL-18分泌。
- p.E148Q与经典FMF突变顺式组合对炎症小体形成提供显著增强。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The p.E148Q variant in pyrin is present in different populations at a frequency of up to 29%, and has been associated with diseases, including vasculitis and FMF. The pathogenicity of p.E148Q in FMF is unclear, even when observed in cis or in trans to a single, typically recessive, pathogenic mutation. We performed functional validation to determine whether p.E148Q increases the ability of pyrin to form an active inflammasome complex in cell lines. METHODS: We interrogated the Australian Autoinflammatory Disease RegistrY (AADRY) to find candidate inheritance patterns for the p.E148Q variant in pyrin. Different pyrin variant combinations were tested in HEK293T cells stably expressing the adaptor protein apoptosis-associated speck-like (ASC), which were analysed by flow cytometry to visualize inflammasome formation, with and without stimulation by Clostridioides difficile toxin B (TcdB). Inflammasome-dependent cytokine secretion was also quantified by ELISA of supernatants from THP-1 cells transduced with lentiviral expression vectors. RESULTS: In AADRY, we observed the p.E148Q allele in individuals with autoinflammatory diseases alone or in conjunction with other pyrin variants. Two FMF families harboured the allele p.E148Q-M694I in cis with dominant heritability. In vitro, p.E148Q pyrin could spontaneously potentiate inflammasome formation, with increased IL-1β and IL-18 secretion. p.E148Q in cis to classical FMF mutations provided significant potentiation of inflammasome formation. CONCLUSION: The p.E148Q variant in pyrin potentiates inflammasome activation in vitro. In cis, this effect is additive to known pathogenic FMF mutations. In some families, this increased effect could explain why FMF segregates as an apparently dominant disease.
引用
- Reygaerts T, Laohamonthonkul P, Hrovat-Schaale K, et al. Pyrin variant E148Q potentiates inflammasome activation and the effect of pathogenic mutations in cis. Rheumatology (Oxford). 2024. PMID: 37481715. doi:10.1093/rheumatology/kead376
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。